Intrawound Administration of Vancomycin in TKA
Not Applicable
Completed
- Conditions
- Knee Osteoarthritis
- Interventions
- Procedure: Intrawound administration of vancomycin after closure of the arthrotomy
- Registration Number
- NCT05338021
- Lead Sponsor
- The Affiliated Hospital of Qingdao University
- Brief Summary
The purpose of this study is to determine the intra-articular and serum levels of vancomycin over the first 24 hours postoperatively after intra-articular administration of a standard dose of vancomycin in primary total knee arthroplasty.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Age between 50 and 80
- Total knee arthroplasty for primary osteoarthritis. Primary diagnosis of knee osteoarthritis
Read More
Exclusion Criteria
- Diminished mental capacity
- Vancomycin allergy
- Chronic kidney disease stage III and stage IV
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Intrawound Administration of Vancomycin Intrawound administration of vancomycin after closure of the arthrotomy After closure of the arthrotomy, 1 g of vancomycin powder suspended in 30ml of normal saline was injected directly into the joint with an 18-gauge needle. Then 20ml of normal saline was injected directly into the joint. Intrawound Administration of Vancomycin combined with epsilon-aminocaproic acid (EACA) Intrawound administration of vancomycin after closure of the arthrotomy After closure of the arthrotomy, 1 g of vancomycin powder suspended in 30ml of normal saline was injected directly into the joint with an 18-gauge needle. Then 4g (20ml) of epsilon-aminocaproic acid (EACA) was injected directly into the joint.
- Primary Outcome Measures
Name Time Method Intra-articular vancomycin concentration 2 hours, 8 hours and 24 hours postoperatively Serum vancomycin concentration 2 hours, 8 hours and 24 hours postoperatively Renal function Postoperative Day 1 and Day 3 blood urea nitrogen (BUN), creatinine (Cr), GFR
Blood loss Postoperative Day 3
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
The affiliated hospital of Qingdao University
🇨🇳Qingdao, Shandong, China